Patients who undergo general and vascular surgical procedures are at risk of developing venous thromboembolism (VTE). [1] [2] [3] [4] [5] [6] In the absence of prophylaxis, the risk of silent deep vein thrombosis (DVT) is 25% (95% confidence interval [CI] 24%-26%) in general surgery, 19% (95% CI 15%-25%) in abdominal vascular surgery, and 15% (95% CI 9%-23%) in peripheral vascular reconstruction (Table 3 .1). In a metaanalysis of 32 studies involving 5091 general surgical patients without prophylaxis, the frequency of clinical pulmonary embolism (PE) was 1.6% (95% CI 1.3%-2.0%) and that of fatal PE was 0.8% (95% CI 0.62%-1.1%). 3 Contrary to the belief that the incidence of postoperative DVT is rare in Asian patients, recent studies have demonstrated that this is not the case. The incidence of DVT was found to be 12.4% (95% CI 10%-15%) in Asians using the fibrinogen uptake test (FUT) in 5 studies. [7] [8] [9] [10] [11] In a meta-analysis of 4 studies, the overall adjusted incidence of PE and fatal PE was 1.0% (95% CI 0.0-2.0) and 0.4% (95% CI 0.0%-1.0%), respectively. 12 A multicenter study performed in Japan in 2006 using routine venography demonstrated that in the absence of prophylaxis, the incidence of postoperative DVT was close to that found in Caucasians (24%). 13 The risk is increased by age, obesity, malignancy, history of VTE, and hereditary or acquired thrombophilia. This risk is also affected by the nature and duration of the operation, type of anesthesia, immobility, dehydration, sepsis, varicose veins, hormone therapy, and pregnancy. [14] [15] [16] [17] [18] Known clinical risk factors allow for classification of patients into high, moderate, and low risk of developing VTE (Tables 3.2 and 3.3 ). Another approach is to use a scoring system based on weighting risk factors according to their tendency to be associated with a thrombotic event. [19] [20] [21] [22] [23] These studies in nearly 10 000 patients demonstrate a linear association between the risk score and the development of symptomatic thrombosis up to 60 days after operation. Scores >8 were associated with 6.5% incidence of clinical events at 30 days and 11.3% incidence at 60 days, respectively.
Studies in patients having abdominal or pelvic surgery demonstrate that the risk continues after discharge from hospital. [24] [25] [26] This finding has implications for the duration of thromboprophylaxis. Patients having operations for cancer have been shown to benefit from 30 days of low-molecular-weight heparin (LMWH; for evidence, see section on cancer).
Despite the use of intraoperative heparin or other perioperative antithrombotic agents, patients having vascular surgery are at moderate risk. In the absence of postoperative prophylaxis, the incidence of asymptomatic DVT is of the order of 18% in patients having abdominal vascular surgery and 15% for those having peripheral vascular reconstruction (Table 3 .1). In the absence of prophylaxis, the reported incidence of proximal DVT (DVT in popliteal or more proximal veins) in patients having abdominal vascular reconstruction is 4% to 6%, 27,28 and the incidence of symptomatic VTE within 90 days of major elective or urgent vascular procedures has been found to be 1.7% to 2.8%. 29 A prospective European registry of vascular surgical procedures showed that the incidence of symptomatic DVT was 0.9% following aortic procedures and 0.7% following femorodistal bypass operations. 30 The National Impatient Sample (20% of all inpatients across the United
